8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001564590-21-043986
Results of operations
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading fdmt-8k_20210812.htm…